Correlation Between Telix Pharmaceuticals and Champion Iron

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Champion Iron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Champion Iron into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals and Champion Iron, you can compare the effects of market volatilities on Telix Pharmaceuticals and Champion Iron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Champion Iron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Champion Iron.

Diversification Opportunities for Telix Pharmaceuticals and Champion Iron

-0.34

Correlation Coefficient

Telix Pharmaceuticals  Champion Iron

Very good diversification

The 3 months correlation between Telix and Champion is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals and Champion Iron in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champion Iron and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals are associated (or correlated) with Champion Iron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champion Iron has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Champion Iron go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Champion Iron

Assuming the 90 days trading horizon Telix Pharmaceuticals is expected to generate 1.14 times more return on investment than Champion Iron. However, Telix Pharmaceuticals is 1.14 times more volatile than Champion Iron. It trades about 0.08 of its potential returns per unit of risk. Champion Iron is currently generating about -0.06 per unit of risk. If you would invest  2,467  in Telix Pharmaceuticals on December 30, 2024 and sell it today you would earn a total of  302.00  from holding Telix Pharmaceuticals or generate 12.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Telix Pharmaceuticals  vs.  Champion Iron

Telix Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Telix Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Champion Iron

Risk-Adjusted Performance

Very Weak

Over the last 90 days Champion Iron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Telix Pharmaceuticals and Champion Iron

The main advantage of trading using opposite Telix Pharmaceuticals and Champion Iron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Champion Iron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champion Iron will offset losses from the drop in Champion Iron's long position.

The idea behind Telix Pharmaceuticals and Champion Iron pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.